Analysis of Cross Sector Adoption and Ancillary Business Capabilities of Cannabinoids, 2020 Report News provided by Share this article Share this article ResearchAndMarkets.com's offering. Cannabinoids as an ingredient for use in pharmaceuticals, F&B, and other industries are steadily gaining in interest across the globe, While R&D and technology developments are on the rise, the industry is still emerging considering the regulatory scenario and the technology limitations. With many technology developers focusing on overcoming challenges and product developmental efforts, new business models need to play with all possible interactions among stakeholders in order to create a smooth environment for commercialization. In countries such as the USA, advancing regulations are encouraging the innovation ecosystem to flourish and new commercialization opportunities are expected to rise in the coming 3-5 years. Competition models are gaining increasing attention in order to face challenges and capture value.